Detalhe da pesquisa
1.
Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4ß7.
J Virol;
91(21)2017 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28814519
2.
Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
J Virol;
90(2): 829-41, 2016 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26512079
3.
Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.
J Virol;
90(19): 8644-60, 2016 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27440894
4.
Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.
J Virol;
87(19): 10855-73, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23903848
5.
Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity.
Protein Expr Purif;
90(1): 34-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23665667
6.
Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.
J Virol;
84(5): 2573-84, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20015987
7.
Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.
J Virol;
82(12): 5912-21, 2008 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18400850
8.
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.
Virology;
514: 106-117, 2018 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29175625
9.
Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques.
Clin Vaccine Immunol;
23(3): 204-12, 2015 Dec 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26718849
10.
Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge.
J Med Primatol;
36(4-5): 254-65, 2007 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17669214